ISSN 0303-5212
 
2024, Vol: 49, Issue: 1
49 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Author_ Certificate.docx
Bank Reciept

Original Research 


Efficacy of Conventional Interferon alpha–2 b plus Ribavirin combination in the treatment of chronic Hepatitis C naive patients

Javed Iqbal Farooqi, Rukhsana Javed Farooqi.

Abstract
Objective: To assess the efficacy of combination therapy of Conventional interferon alpha-2b plus ribavirin in patients of chronic hepatitis C.
Methods: Records of 65 patients (43 males and 22 females) of chronic hepatitis C treated with combination therapy of interferon alpha-2b plus ribavirin from January 2003 to December 2003 were analyzed for base-line parameters, response rates and any adverse effects.
Results: End-treatment response was found in 86.04% male patients and 86.36% female patients. Sustained response was found in 81.39% male patients and 86.36% female patients.
Conclusions: The study shows that conventional interferon plus ribavirin combination therapy remains an effective therapy in the treatment of chronic hepatitis C naive patients in our set-up. (Rawal Med J 2005;30:9-11).

Key words: Hepatitis C naïve patients, interferon, ribavirin


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Javed Iqbal Farooqi
Articles by Rukhsana Javed Farooqi
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Javed Iqbal Farooqi, Rukhsana Javed Farooqi. Efficacy of Conventional Interferon alpha–2 b plus Ribavirin combination in the treatment of chronic Hepatitis C naive patients . RMJ. 2005; 30(1): 9-11.

Web Style

Javed Iqbal Farooqi, Rukhsana Javed Farooqi. Efficacy of Conventional Interferon alpha–2 b plus Ribavirin combination in the treatment of chronic Hepatitis C naive patients . https://www.rmj.org.pk/?mno=8841 [Access: December 08, 2023].

AMA (American Medical Association) Style

Javed Iqbal Farooqi, Rukhsana Javed Farooqi. Efficacy of Conventional Interferon alpha–2 b plus Ribavirin combination in the treatment of chronic Hepatitis C naive patients . RMJ. 2005; 30(1): 9-11.


Vancouver/ICMJE Style

Javed Iqbal Farooqi, Rukhsana Javed Farooqi. Efficacy of Conventional Interferon alpha–2 b plus Ribavirin combination in the treatment of chronic Hepatitis C naive patients . RMJ. (2005), [cited December 08, 2023]; 30(1): 9-11.


Harvard Style

Javed Iqbal Farooqi, Rukhsana Javed Farooqi (2005) Efficacy of Conventional Interferon alpha–2 b plus Ribavirin combination in the treatment of chronic Hepatitis C naive patients . RMJ, 30 (1), 9-11.


Turabian Style

Javed Iqbal Farooqi, Rukhsana Javed Farooqi. 2005. Efficacy of Conventional Interferon alpha–2 b plus Ribavirin combination in the treatment of chronic Hepatitis C naive patients . Rawal Medical Journal, 30 (1), 9-11.


Chicago Style

Javed Iqbal Farooqi, Rukhsana Javed Farooqi. "Efficacy of Conventional Interferon alpha–2 b plus Ribavirin combination in the treatment of chronic Hepatitis C naive patients ." Rawal Medical Journal 30 (2005), 9-11.


MLA (The Modern Language Association) Style

Javed Iqbal Farooqi, Rukhsana Javed Farooqi. "Efficacy of Conventional Interferon alpha–2 b plus Ribavirin combination in the treatment of chronic Hepatitis C naive patients ." Rawal Medical Journal 30.1 (2005), 9-11. Print.


APA (American Psychological Association) Style

Javed Iqbal Farooqi, Rukhsana Javed Farooqi (2005) Efficacy of Conventional Interferon alpha–2 b plus Ribavirin combination in the treatment of chronic Hepatitis C naive patients . Rawal Medical Journal, 30 (1), 9-11.


Author LoginReviewer LoginEditorial PoliciesConflict of Interest PolicyPlagiarism PolicyAdvertising Policy

About Rawal Medical Journal

Publication, subscription and Editorial office PMA House G/220-B Liaquat Road, Rawalpindi. Phone: 051-555-9812, Fax: 051-553-7088 Email: drnkhokhar@ya ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information